Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

EltaMD Unveils UV Clear Blemish-Prone & Oil Balancing SPF 50, a Breakthrough Sunscreen for Acne-Prone Skin, on National Dermatologist Day

EltaMD Unveils UV Clear Blemish-Prone & Oil Balancing SPF 50, a Breakthrough Sunscreen for Acne-Prone Skin, on National Dermatologist Day

News provided by

EltaMD

Mar 13, 2026, 12:00 ET

Share this article

Share toX

Share this article

Share toX

The #1 Dermatologist-Recommended Professional Sunscreen Brand Will Ring the Closing Bell at the New York Stock Exchange to Mark the Occasion

SCOTTSDALE, Ariz., March 13, 2026 /PRNewswire/ -- Today, on the third annual National Dermatologist Day, EltaMD, the #1 Dermatologist Recommended, Trusted & Personally Used Professional Sunscreen Brand, introduces UV Clear Blemish-Prone & Oil Balancing SPF 50, a sunscreen made for and clinically proven to protect and correct oily, acne-prone skin.

Continue Reading
EltaMD Unveils UV Clear Blemish-Prone & Oil Balancing SPF 50, a Breakthrough Sunscreen for Acne-Prone Skin, on National Dermatologist Day
EltaMD Unveils UV Clear Blemish-Prone & Oil Balancing SPF 50, a Breakthrough Sunscreen for Acne-Prone Skin, on National Dermatologist Day
(Top Image) Clinically proven reduction in blemishes* in 12 weeks. (Bottom Image) Clinically proven reduction in oil and shine* in 12 weeks.  *study population: 43 subjects, ages 18-45, all Fitzpatrick, with acne-prone, oily skin. PIH/PIE, appearance of pores and comodones. Test product/use regimen: Applied daily to clean face and neck 15 minutes before sun exposure and reapplied at least every two hours if under the sun. Photos not retouched.
(Top Image) Clinically proven reduction in blemishes* in 12 weeks. (Bottom Image) Clinically proven reduction in oil and shine* in 12 weeks. *study population: 43 subjects, ages 18-45, all Fitzpatrick, with acne-prone, oily skin. PIH/PIE, appearance of pores and comodones. Test product/use regimen: Applied daily to clean face and neck 15 minutes before sun exposure and reapplied at least every two hours if under the sun. Photos not retouched.

Building on the brand's best-selling UV Clear franchise, long considered a dermatologist-trusted staple for acne-prone skin, UV Clear Blemish-Prone & Oil Balancing SPF 50 was designed to target active breakouts and excess oil, while maintaining the lightweight finish that made UV Clear a dermatologist favorite. The non-comedogenic and non-acnegenic formula delivers a 65% reduction in visible blemishes in just 12 weeks*, setting a new standard for suncare for acne-prone skin.

The Science of Clear Skin
At the core of this innovation is the Zinc-AOX Pro Technology™, a blend of 11% high-purity Zinc Oxide and four potent antioxidants. This technology works in tandem with 5% Niacinamide to create a multi-dimensional approach to blemish management: while the Zinc-AOX Pro Technology shields against UV rays and environmental aggressors like blue light and diesel exhaust, the high-concentration Niacinamide works gently to visibly reduce blemishes and shine.

In a 12-week clinical study of subjects with acne-prone and oily skin, the formula demonstrated significant improvement starting as early as week 4, with results progressively increasing through the end of the study. At the 12-week mark, participants saw*:

  • 65% reduction in the appearance of blemishes
  • 61% reduction in excess oil and shine
  • 25% reduction in the appearance of pore size

A Commitment to the Dermatology Community
The launch coincides with National Dermatologist Day, which was established by the brand in 2024 to honor the experts who guide patients through their lifelong skin journeys. This year's celebration carries additional significance as it coincides with the 220th anniversary of EltaMD's parent company, Colgate-Palmolive. Representing Colgate-Palmolive on the trading floor, EltaMD will ring the Closing Bell at the New York Stock Exchange, celebrating the dermatology community while introducing its newest innovation.

"Dermatologists have an incredible impact on patients' confidence, health, and long-term skin outcomes," said Echo Sandburg, Chief Brand Officer at Colgate-Palmolive Skin Health Group. "Launching this formula on National Dermatologist Day reflects our deep partnership with the dermatology community and our commitment to delivering clinically tested formulas that address the real concerns dermatologists treat every day."

Availability
UV Clear Blemish-Prone & Oil Balancing SPF 50 ($49) launches March 13 in authorized professional offices nationwide, followed by a broader rollout beginning April 13 on EltaMD.com and authorized online retailers.

To learn more about EltaMD and its full lineup of dermatologist-recommended skincare products, visit https://eltamd.com.

*Based on a 12-week clinical study of 43 subjects with acne-prone and oily skin.

About EltaMD
Founded in 1882, EltaMD began with healing formulas designed for the most sensitive, compromised skin – becoming a trusted staple in hospitals and burn centers worldwide. This clinical heritage established the brand as a global authority in wound healing and inspired its focus on innovative, zinc oxide–based formulas that deliver high-level UV protection while supporting skin repair.

Today, EltaMD is the #1 professional sunscreen brand – recommended, trusted, and personally used by dermatologists more than any other professional sunscreen. With dermatologists at the center of its mission, EltaMD bridges clinical expertise and everyday skin needs through personalized protection, treatment, and care. Its lightweight, non-greasy formulas blend seamlessly across skin tones, combining advanced science with elegant wear to not only protect skin from UVA/UVB damage, but help restore and transform it – so everyone can step into the sun, and into life, with confidence.

Media Contact
5W Public Relations
[email protected]  

SOURCE EltaMD

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.